PortfoliosLab logoPortfoliosLab logo
API vs. BMEA
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

API vs. BMEA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Agora, Inc. (API) and Biomea Fusion, Inc. (BMEA). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

API vs. BMEA - Yearly Performance Comparison


2026 (YTD)20252024202320222021
API
Agora, Inc.
-13.02%-2.16%58.17%-32.74%-75.88%-71.43%
BMEA
Biomea Fusion, Inc.
23.39%-68.04%-73.28%72.24%13.15%-59.95%

Fundamentals

Market Cap

API:

$343.28M

BMEA:

$110.62M

EPS

API:

$0.10

BMEA:

-$1.21

PB Ratio

API:

0.61

BMEA:

3.74

Total Revenue (TTM)

API:

$141.27M

BMEA:

$0.00

Gross Profit (TTM)

API:

$93.80M

BMEA:

-$947.00K

EBITDA (TTM)

API:

$10.35M

BMEA:

-$77.14M

Returns By Period

In the year-to-date period, API achieves a -13.02% return, which is significantly lower than BMEA's 23.39% return.


API

1D
2.31%
1M
-24.20%
YTD
-13.02%
6M
-7.33%
1Y
-11.94%
3Y*
-0.74%
5Y*
-41.95%
10Y*

BMEA

1D
15.91%
1M
11.68%
YTD
23.39%
6M
-24.26%
1Y
-28.17%
3Y*
-63.32%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Agora, Inc.

Biomea Fusion, Inc.

Often compared with API:
API vs. JFUAPI vs. SCHG
Often compared with BMEA:
BMEA vs. LAZR

Return for Risk

API vs. BMEA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

API
API Risk / Return Rank: 2626
Overall Rank
API Sharpe Ratio Rank: 3131
Sharpe Ratio Rank
API Sortino Ratio Rank: 3030
Sortino Ratio Rank
API Omega Ratio Rank: 3131
Omega Ratio Rank
API Calmar Ratio Rank: 2525
Calmar Ratio Rank
API Martin Ratio Rank: 1414
Martin Ratio Rank

BMEA
BMEA Risk / Return Rank: 3333
Overall Rank
BMEA Sharpe Ratio Rank: 3030
Sharpe Ratio Rank
BMEA Sortino Ratio Rank: 4141
Sortino Ratio Rank
BMEA Omega Ratio Rank: 4141
Omega Ratio Rank
BMEA Calmar Ratio Rank: 2525
Calmar Ratio Rank
BMEA Martin Ratio Rank: 2929
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

API vs. BMEA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Agora, Inc. (API) and Biomea Fusion, Inc. (BMEA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


APIBMEADifference

Sharpe ratio

Return per unit of total volatility

-0.23

-0.24

+0.01

Sortino ratio

Return per unit of downside risk

0.02

0.46

-0.44

Omega ratio

Gain probability vs. loss probability

1.00

1.06

-0.06

Calmar ratio

Return relative to maximum drawdown

-0.52

-0.50

-0.02

Martin ratio

Return relative to average drawdown

-1.37

-0.76

-0.61

API vs. BMEA - Sharpe Ratio Comparison

The current API Sharpe Ratio is -0.23, which is comparable to the BMEA Sharpe Ratio of -0.24. The chart below compares the historical Sharpe Ratios of API and BMEA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


APIBMEADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.23

-0.24

+0.01

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.46

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.40

-0.36

-0.04

Correlation

The correlation between API and BMEA is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

API vs. BMEA - Dividend Comparison

Neither API nor BMEA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

API vs. BMEA - Drawdown Comparison

The maximum API drawdown since its inception was -98.28%, roughly equal to the maximum BMEA drawdown of -97.71%. Use the drawdown chart below to compare losses from any high point for API and BMEA.


Loading graphics...

Drawdown Indicators


APIBMEADifference

Max Drawdown

Largest peak-to-trough decline

-98.28%

-97.71%

-0.57%

Max Drawdown (1Y)

Largest decline over 1 year

-35.40%

-66.99%

+31.59%

Max Drawdown (5Y)

Largest decline over 5 years

-96.94%

Current Drawdown

Current decline from peak

-96.66%

-96.34%

-0.32%

Average Drawdown

Average peak-to-trough decline

-83.22%

-65.68%

-17.54%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.48%

43.99%

-30.51%

Volatility

API vs. BMEA - Volatility Comparison

The current volatility for Agora, Inc. (API) is 11.99%, while Biomea Fusion, Inc. (BMEA) has a volatility of 26.96%. This indicates that API experiences smaller price fluctuations and is considered to be less risky than BMEA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


APIBMEADifference

Volatility (1M)

Calculated over the trailing 1-month period

11.99%

26.96%

-14.97%

Volatility (6M)

Calculated over the trailing 6-month period

32.96%

72.42%

-39.46%

Volatility (1Y)

Calculated over the trailing 1-year period

52.61%

118.98%

-66.37%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

92.08%

109.95%

-17.87%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

93.32%

109.95%

-16.63%

Financials

API vs. BMEA - Financials Comparison

This section allows you to compare key financial metrics between Agora, Inc. and Biomea Fusion, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00M50.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
38.32M
0
(API) Total Revenue
(BMEA) Total Revenue
Values in USD except per share items